mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.006 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.007 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.007 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.007 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.007 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.007 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.007 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.007 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.007 |